心脏结节病中氧化应激增强与室壁瘤对风险预测的价值
该前瞻性观察队列研究纳入61例18F-FDG异常积聚的心脏结节病患者,随访中位46个月,15例发生持续性室速或心源性猝死。尿8-OHdG浓度与室壁瘤存在是首次sVT/SCD的独立预测因子,联合评估可增强风险分层。
要点
- 尿8-OHdG≥14.9 ng/mg·Cr且存在室壁瘤者sVT/SCD风险显著增加。
- 尿8-OHdG和室壁瘤是心脏结节病患者首次sVT/SCD的独立预测因子。
- 基线尿8-OHdG与室壁瘤有助于识别高危心脏结节病患者。
核心结论
- 尿8-OHdG浓度和室壁瘤存在是心脏结节病患者首次持续性室速或心源性猝死的强预测因子。
- 联合尿8-OHdG≥14.9 ng/mg·Cr与室壁瘤可显著提高风险分层能力。
研究设计与样本
- 前瞻性观察队列研究,纳入2008年6月至2020年3月在本院按日本或心律学会指南诊断的心脏结节病患者。
主要发现
- 随访期间61例中15例发生首次sVT(n=12)或SCD(n=3)。
- Cox比例风险模型显示尿8-OHdG浓度和室壁瘤存在是首次sVT/SCD的独立预测因子。
- 预测首次sVT/SCD的尿8-OHdG截断值为14.9 ng/mg·Cr。
- 尿8-OHdG≥14.9 ng/mg·Cr且存在室壁瘤的患者sVT/SCD风险显著增加。
关键数值与推荐
- 尿8-OHdG预测首次sVT/SCD的截断值为14.9 ng/mg·Cr。
- 尿8-OHdG≥14.9 ng/mg·Cr且存在室壁瘤者sVT/SCD风险显著增加。
临床怎么用
- 对18F-FDG异常积聚的心脏结节病患者,可检测尿8-OHdG并评估室壁瘤以进行风险分层。
- 尿8-OHdG≥14.9 ng/mg·Cr且存在室壁瘤的患者应考虑更密切监测或强化管理。
局限性
- 单中心研究,样本量较小(61例随访)。
- 仅纳入18F-FDG异常积聚患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sudden cardiac death (SCD) is the major cause of death in cardiac sarcoidosis (CS). We aimed to identify the prognostic markers for sustained ventricular tachycardia (sVT) and SCD in patients with CS. METHODS: We performed a prospective observational cohort study for patients with CS diagnosed according to the Japanese or Heart Rhythm Society guidelines between June 2008 and March 2020 in our hospital. The primary endpoint was a composite of the first sVT and SCD. The levels of urinary 8-hydroxy-2'-deoxyguanosine (U-8-OHdG), a marker of oxidative DNA damage that reflects the inflammatory activity of CS, other biomarkers, and indices of cardiac function and renal function were measured on admission. RESULTS: Eighty-nine consecutive patients with CS were enrolled; 28 patients with no abnormal 18F-fluorodeoxyglucose (18F-FDG) accumulation in the heart were excluded and 61 patients with abnormal 18F-FDG accumulation were followed up for a median of 46 months (IQR: 20-84). During the follow-up period, 15 of 61 patients showed sVT (n=12) or SCD (n=3). A Cox proportional hazard model showed that U-8-OHdG concentration and presence of ventricular aneurysm (VA) were independent predictors of first sVT/SCD. The cut-off U-8-OHdG concentration for predicting first sVT/SCD was 14.9 ng/mg·Cr. Patients with U-8-OHdG concentration ≥14.9 ng/mg·Cr and VA showed a significantly increased risk of sVT/SCD. CONCLUSIONS: U-8-OHdG and presence of VA were powerful predictors of first sVT/SCD in patients with CS, facilitating the stratification of cardiac events and providing relevant information about the substrates of ventricular tachycardia.
引用
- Yoshitomi R, Kobayashi S, Yano Y, et al. Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis. Heart. 2022. PMID: 35078868. doi:10.1136/heartjnl-2021-320244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。